Price Alert

Charles River Laboratorie... (CRL)

NYSE: CRL · Real-Time Price · USD

157.13

1.33 (0.85%)

At close: Aug 15, 2025, 3:03 PM

Charles River Laboratories International Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 28, 2025	Mar 29, 2025	Dec 28, 2024	Sep 28, 2024	Jun 29, 2024	Mar 30, 2024	Dec 30, 2023	Sep 30, 2023	Jul 1, 2023	Apr 1, 2023	Dec 31, 2022	Sep 24, 2022	Jun 25, 2022	Mar 26, 2022	Dec 25, 2021	Sep 25, 2021	Jun 26, 2021	Mar 27, 2021
Revenue	1.03B	984.17M	1B	1.01B	1.03B	1.01B	1.01B	1.03B	1.06B	1.03B	1.1B	989.16M	973.13M	913.93M	905.05M	895.94M	914.61M	824.57M
Cost of Revenue	675.07M	666.44M	718.3M	660.74M	672.4M	666.72M	649.39M	664.78M	660.96M	651.72M	700.96M	618.93M	654.58M	577.11M	557.94M	558.71M	572.59M	516.29M
Gross Profit	357.07M	317.73M	284.24M	349.02M	353.71M	344.84M	364.08M	361.84M	398.98M	377.65M	398.88M	370.22M	318.56M	336.82M	347.11M	337.23M	342.02M	308.28M
Operating Income	100.13M	74.67M	-167.69M	117.41M	151.65M	125.98M	132.92M	151.5M	164.94M	167.89M	279.7M	150.98M	188.78M	148.78M	172.81M	155.8M	137.55M	123.7M
Interest Income	1.1M	1.4M	1.83M	1.53M	3.01M	2.2M	1.59M	1.37M	1.43M	806K	343K	122K	188K	127K	309K	137K	171K	35K
Pretax Income	71.42M	35.98M	-216.79M	91.24M	119.65M	99.01M	208.71M	112.87M	128.66M	131.04M	244.92M	123.11M	144.11M	110.85M	163.64M	123.27M	127.5M	66.3M
Net Income	52.33M	25.47M	-215.7M	68.68M	89.99M	67.33M	187.08M	87.39M	97.02M	103.13M	187.41M	96.47M	109.32M	93.02M	137.58M	103.43M	88.45M	61.53M
Selling & General & Admin	191.55M	177.8M	195.71M	199.21M	169.79M	186.29M	197.14M	176.11M	199.76M	174.85M	199.64M	183.71M	129.78M	150.03M	144.11M	148.57M	171.5M	155.73M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	65.38M	65.26M	256.22M	32.4M	32.27M	32.58M	34.02M	34.23M	34.27M	34.92M	35.43M	-16.62M	n/a	38.01M	2.07M	-16.21M	5.96M	-27.72M
Operating Expenses	256.93M	243.06M	451.93M	231.62M	202.06M	218.87M	231.16M	210.34M	234.03M	209.76M	235.07M	219.25M	129.78M	188.04M	174.31M	181.43M	204.47M	184.57M
Interest Expense	29.97M	27.88M	28.23M	30.28M	32.77M	35M	33.54M	33.74M	35.04M	34.38M	34.78M	11.38M	3.7M	9.43M	11.55M	16.45M	16.19M	29.72M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	932M	909.5M	1.17B	892.36M	874.47M	885.58M	880.55M	875.12M	894.99M	861.48M	936.03M	838.18M	784.36M	765.15M	732.24M	740.13M	777.06M	700.86M
Income Tax Expense	18.73M	10.1M	-3.04M	20.95M	25.39M	24.53M	19.75M	24.85M	29.22M	27.09M	55.81M	25.5M	33.45M	15.62M	23.82M	18.11M	37.58M	2.37M
Shares Outstanding (Basic)	49.15M	50.68M	51.14M	51.39M	51.55M	51.44M	51.31M	51.28M	51.22M	51.31M	50.91M	50.87M	50.82M	50.64M	50.47M	50.42M	50.3M	49.98M
Shares Outstanding (Diluted)	49.32M	50.85M	51.14M	51.58M	51.85M	51.84M	51.62M	51.61M	51.47M	51.43M	51.38M	51.28M	51.28M	51.33M	51.55M	51.56M	51.33M	51.08M
EPS (Basic)	1.06	0.50	-4.22	1.34	1.75	1.42	3.65	1.70	1.89	2.01	3.68	1.90	2.15	1.84	2.73	2.05	1.76	1.23
EPS (Diluted)	1.06	0.50	-4.22	1.33	1.74	1.41	3.62	1.69	1.89	2.01	3.65	1.88	2.13	1.81	2.67	2.01	1.72	1.20
EBITDA	220.89M	184.23M	-86.45M	209.72M	238.5M	219.37M	322.76M	225.49M	241.38M	242.49M	357.25M	226.49M	244.76M	186.15M	253.04M	213.46M	217.15M	157.53M
EBIT	101.39M	63.86M	-188.56M	121.53M	152.42M	134.01M	242.25M	146.62M	163.71M	165.42M	279.7M	134.48M	147.82M	120.28M	184.94M	139.72M	143.69M	96.02M
Depreciation & Amortization	119.51M	120.36M	102.1M	88.2M	86.08M	85.36M	80.51M	78.87M	77.67M	77.07M	77.55M	74.61M	76.42M	75.3M	68.1M	68.69M	68.11M	61.51M